Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Journal of Affective Disorders
|
December 4, 2019
The role of relapse prevention for depression in collaborative care: A systematic review
Andrew S Moriarty, Peter A Coventry, Joanna L Hudson, et al.
NEJM Evidence
|
February 6, 2024
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
Karim Fizazi, Alice Bernard-Tessier, Guilhem Roubaud, et al.
Nature Communications
|
April 17, 2024
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary
Alicia-Marie Conway, Simon P Pearce, Alexandra Clipson, et al.
Gastroenterology
|
October 28, 2017
Exome-Wide Association Study of Pancreatic Cancer Risk
Robert C Grant, Robert E Denroche, Ayelet Borgida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Jia Liu, Max Farrow, Lesley Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2025
Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors
Jia Liu, Anna R Minchom, Alastair Greystoke, et al.
Nature Medicine
|
May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
Thomas Powles, Danielle Carroll, Simon Chowdhury, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 11, 2012
Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials
Rebecca J Brais, Susan E Davies, Maria O'Donovan, et al.
Gut
|
April 3, 2012
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A Jacobetz, Derek S Chan, Albrecht Neesse, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Journal of Affective Disorders
|
December 4, 2019
The role of relapse prevention for depression in collaborative care: A systematic review
Andrew S Moriarty, Peter A Coventry, Joanna L Hudson, et al.
NEJM Evidence
|
February 6, 2024
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
Karim Fizazi, Alice Bernard-Tessier, Guilhem Roubaud, et al.
Nature Communications
|
April 17, 2024
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary
Alicia-Marie Conway, Simon P Pearce, Alexandra Clipson, et al.
Gastroenterology
|
October 28, 2017
Exome-Wide Association Study of Pancreatic Cancer Risk
Robert C Grant, Robert E Denroche, Ayelet Borgida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Jia Liu, Max Farrow, Lesley Seymour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2025
Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors
Jia Liu, Anna R Minchom, Alastair Greystoke, et al.
Nature Medicine
|
May 4, 2021
An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer
Thomas Powles, Danielle Carroll, Simon Chowdhury, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
April 11, 2012
Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials
Rebecca J Brais, Susan E Davies, Maria O'Donovan, et al.
Gut
|
April 3, 2012
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A Jacobetz, Derek S Chan, Albrecht Neesse, et al.
Page
of 9